Mechanism of thromboxane A2-stimulated cell proliferation of human colonic cancer cells

King's College London (2005) J Physiol 565P, C124

Communications: Mechanism of thromboxane A2-stimulated cell proliferation of human colonic cancer cells

Sakai, Hideki ; Suzuki, Tomoyuki ; Horikawa, Naoki ; Ukai, Masashi ; Tauchi, Katsunori ; Minamimura, Tetsuji ; Tabuchi, Yoshiaki ; Morii, Magotoshi ; Tsukada, Kazuhiro ; Takeguchi, Noriaki ;

1. Department of Pharmaceutical Physiology, Toyama Medical and Pharmaceutical University, Toyama, Japan. 2. Department of Surgery II, Toyama Medical and Pharmaceutical University, Toyama, Japan. 3. Life Science Research Centre, Toyama Medical and Pharmaceutical University, Toyama, Japan.

View other abstracts by:


Tumor growth of colorectal cancers accompanies up-regulation of inducible cyclooxygenase-2, which catalyzes a key step in conversion of arachidonic acid to prostaglandin H2 (PGH2) (Marx, 2001). In the downstream of COX, thromboxane synthase (TXS) catalyzes the conversion of PGH2 to thromboxane A2 (TXA2). We found recently that TXS is significantly up-regulated in the human colorectal carcinomas (Sakai et al. 2003). TXS was also highly expressed in human colonic cancer cell lines. Disruption of TXS protein by the antisense oligonucleotide inhibited the proliferation of the cancer cells (Suzuki et al. 2004). Herein we investigated if the Kv7.1 (KvLQT1), a voltage-dependent K+ channel, is involved in the TXA2-induced cell proliferation. Human colorectal cancer tissue and its accompanying normal mucosa were obtained from surgical resection of Japanese patients in accordance with the recommendations of the Declaration of Helsinki and with the ethics committee approval. The expression of Kv7.1 protein in human tissues and human colonic carcinoma cell lines was examined by Western blotting. Cell proliferation assay was performed by counting the number of the cell in a 12-well plate. Results are shown as means ± S.E.M. The data were statistically analysed using one-way ANOVA and Tukey’s multiple comparison test. We compared the expression levels of Kv7.1 protein between human colorectal cancer tissue and its accompanying normal mucosa. It was found that Kv7.1 is up-regulated in human cancer tissues (70 kDa; 10 of 10 cases, 100%). Significant expression of Kv7.1 protein was also observed in the human colonic cancer cell lines such as KM12-L4, HT-29, T-84, WiDr (n = 3). A stable analog of TXA2 (STA2; 0.1 μM) stimulated the proliferation of KM12-L4 cells from (1.31 ± 0.03) x 105 to (1.65 ± 0.04) x 105 cells (n = 5, P < 0.01), and the STA2-induced effect was completely inhibited by chromanol 293B (10 μM), an inhibitor of Kv7.1 (n = 5, P < 0.01). STA2 (0.1 μM) significantly increased the expression level of Kv7.1 protein by (2.09 ± 0.09)-fold in the KM12-L4 cells (n = 4, P < 0.01). In the cells, STA2 also increased the chromanol 293B-sensitive K+ current from 8.87 ± 1.01 to 16.91 ± 1.25 pA pF-1 at +30 mV (n = 7, P < 0.01). These results suggest that paralleled up-regulations of TXS and Kv7.1 channel may be involved in the tumor growth of human colorectum.



Where applicable, experiments conform with Society ethical requirements.

Site search

Filter

Content Type